Top Clinical Trials companies in Sweden by Dividend Yield

This ranking features the top 65 Clinical Trials companies in Sweden ranked by Dividend Yield, averaging a Dividend Yield of NA, for June 30, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2

Frequently Asked Questions

Which Clinical Trials company in Sweden has the highest Dividend Yield ?

The Clinical Trials company in Sweden with the highest Dividend Yield is Sleep Cycle AB (publ) (Stockholm Stock Exchange: SLEEP.ST) at 6.41%.
Which Clinical Trials company in Sweden has the lowest Dividend Yield ?

The Clinical Trials company in Sweden with the lowest Dividend Yield is Infant Bacterial Therapeutics AB (publ) (Stockholm Stock Exchange: IBT-B.ST) at None.

What are the top 10 Clinical Trials companies in Sweden by Dividend Yield ?

The top 10 Clinical Trials companies in Sweden by Dividend Yield are Sleep Cycle AB (publ), Elekta AB (publ), Arjo AB (publ), CellaVision AB (publ), Vitrolife AB (publ), RaySearch Laboratories AB (publ), Ascelia Pharma AB (publ), AlzeCure Pharma AB (publ), Alzinova AB (publ) and Alligator Bioscience AB (publ).
What are the bottom 10 Clinical Trials companies in Sweden by Dividend Yield ?

The bottom 10 Clinical Trials companies in Sweden by Dividend Yield are Infant Bacterial Therapeutics AB (publ), Kancera AB (publ), Elicera Therapeutics AB (publ), Guard Therapeutics International AB (publ), Isofol Medical AB (publ), Intervacc AB (publ), Aptahem AB (publ), BioArctic AB (publ), Genovis AB (publ.) and Lipum AB (publ).